Search

everythinglearnresearchcommunity

for

Search:↓

Baseline severity and relapse history affect alopecia areata treatment and recurrence.

Baricitinib shows promise in improving frontal fibrosing alopecia symptoms.

A new surgical method using special sutures significantly reduced wound size and prevented disease return in patients with a scarring scalp condition.

Treating seborrheic alopecia with Traditional Chinese Medicine by balancing internal factors can be effective.

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

Spironolactone safely and effectively treats hair loss in female scarring alopecia patients.

Finasteride shows promise for female hair loss, but more research needed.

Both dermatologists and patients in Japan agree that treatment success for alopecia areata is having 20% or less scalp hair loss.

Degenerative changes in the lower cervical spine are common in patients with abnormal scalp sensations, with some improvement seen using pain medication and physical therapy.

Mind-body techniques and a team approach can help manage skin conditions linked to psychological factors.

Baricitinib effectively improves symptoms of atopic dermatitis and alopecia areata with few side effects.

The document concludes that while there are various treatments for Alopecia Areata, there is no cure, and individualized treatment plans are essential due to varying effectiveness.

Combining imiquimod with diphenylcyclopropenone may improve treatment outcomes for alopecia areata patients who don't respond to diphenylcyclopropenone alone.

Avoiding dyed wigs and clothing improved severe allergic reactions in a woman treated with diphencyprone.

Low-dose naltrexone may help reduce redness in certain scalp conditions.

Geraniol effectively treats scabies and is safe for use.

The document concludes that skin aging in women can be caused by UV exposure and hormonal changes, and treatments like hormone replacement therapy and various skin therapies can help.

Janus kinase inhibitors show promise in treating autoimmune skin diseases.

Low-level laser therapy did not reduce licking or improve lesions in dogs with ALD but did increase hair growth.

Using tacalcitol ointment with photodynamic therapy may effectively treat follicular mucinosis with scalp hair loss.

Method B with propylene glycol is better for stable low-concentration DPCP solutions for alopecia areata.

More research with diverse participants is needed to determine the effectiveness of photobiomodulation devices for hair loss treatment.

Hair and scalp pain is more common and severe in breast cancer patients on chemotherapy than those on tamoxifen.

Combining plasma rich in growth factors with hair transplant surgery may lead to faster recovery and better outcomes for hair loss treatment.

5% minoxidil foam is a safe, effective treatment for male pattern hair loss, with increased hair count and few side effects.

A lotion with Centella asiatica extract reduced hair loss by 41% and increased hair strength without side effects.

The symposium showed that stem cells are key for understanding and treating skin diseases and for developing new skin models and therapies.

Both fluoxetine and clomipramine effectively treat dog lick dermatitis, but fluoxetine works faster with lower recurrence, while clomipramine has fewer side effects.

5% and 2% minoxidil solutions effectively promote hair growth and reduce hair loss, with 5% being slightly more effective but having more side effects.

Atopic dermatitis is common in developing countries, but many patients receive poor care due to inconsistent guidelines and lack of resources.